Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.

Although drug addiction is classically studied in a neuron-centric way, Vanderbilt researchers have discovered that the immune system also plays a critical role.

When 17-year-old Ray Cruz was invited to perform at the Ryman Auditorium, he agreed to do it under one condition — that his doctor perform alongside him.

Curiosity is the spark that has always energized and illuminated Eric Shinohara’s life — curiosity about the natural world, about other people and about how to help those individuals.

Patient Flow Nurses (PFNs) are passionate about their role — helping expedite the discharge of patients to decrease length of stay, reduce readmissions and open beds for other patients.

Research led by Vanderbilt-Ingram Cancer Center (VICC) investigators may have solved a mystery about why a targeted therapy stops working in a small group of breast cancer patients.

Researchers in the Vanderbilt Institute for Global Health are testing whether a unique “couples-centered” intervention developed in the southern African nation of Mozambique can reduce mother-to-child transmission of HIV.